GlassScriptPhysician profile
Hillary Jo Edelman
NPI 1780046185
$2,153.43
in general payments reported to CMS, 2019-2025
22 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.50 · 2020: $266 · 2021: $58.93 · 2022: $856 · 2023: $389 · 2024: $296 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $596.46 | 2020-2025 | Lo Loestrin Fe, Liletta |
| Exeltis, USA INC. | $167.32 | 2022-2025 | Slynd |
| Mayne Pharma Commercial LLC | $163.01 | 2022-2025 | |
| Avion Pharmaceuticals | $161.47 | 2020-2022 | |
| Organon LLC | $128.03 | 2022-2024 | Nexplanon |
| Aspira Women'S Health INC | $127.54 | 2022 | |
| Hologic Sales and Service, LLC | $118.26 | 2021-2025 | Omni Hysteroscope, Myosure Tissue Removal Device, Aptima |
| Janssen Pharmaceuticals, INC | $118.05 | 2020 | |
| Daiichi Sankyo INC. | $103.28 | 2020 | |
| Coopersurgical, INC. | $78.87 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Myovant Sciences INC. | $56.60 | 2022 | |
| Astellas Pharma US INC | $54.96 | 2024 | Veozah |
| Channel Medsystems, INC. | $50.51 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $37.56 | 2024 | Gardasil, Gardasil 9 |
| Biogen, INC. | $36.62 | 2025 | Zurzuvae |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $29.31 | 2023 | Myfembree |
| Novo Nordisk INC | $28.46 | 2019-2023 | Wegovy |
| Mylan Pharmaceuticals INC. | $25.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.89 | 2019 | |
| Exact Sciences Corporation | $18.88 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $17.60 | 2024 | |
| Therapeuticsmd, INC. | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Edelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.